Patient factors associated with lung transplant referral and waitlist for patients with cystic fibrosis and pulmonary fibrosis

Autor: Edward R. Garrity, Milda R. Saunders, Christopher H. Wigfield, Monica B. Vela, Yuan Liu, Tanya M Rudakevych
Rok vydání: 2017
Předmět:
Graft Rejection
Male
Cystic Fibrosis
Pulmonary Fibrosis
Comorbidity
Kaplan-Meier Estimate
030230 surgery
Severity of Illness Index
Cystic fibrosis
Insurance Coverage
Cohort Studies
0302 clinical medicine
Pulmonary fibrosis
Referral and Consultation
Depression (differential diagnoses)
Academic Medical Centers
Graft Survival
Middle Aged
Respiratory Function Tests
Anxiety
Female
medicine.symptom
Cardiology and Cardiovascular Medicine
Lung Transplantation
Adult
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Waiting Lists
Referral
Risk Assessment
Statistics
Nonparametric

Article
03 medical and health sciences
Internal medicine
medicine
Humans
Retrospective Studies
Transplantation
business.industry
Patient Selection
Retrospective cohort study
medicine.disease
Survival Analysis
United States
030228 respiratory system
Physical therapy
Surgery
business
Body mass index
Lung allocation score
Zdroj: The Journal of Heart and Lung Transplantation. 36:264-271
ISSN: 1053-2498
DOI: 10.1016/j.healun.2016.08.016
Popis: BACKGROUND: Since 2005, the Lung Allocation Score (LAS) has prioritized patient benefit and post-transplant survival, reducing waitlist to transplant time to less than 200 days and decreasing mortality on the waitlist. A current challenge is the wait for the waitlist—the time between patient’s transplant-eligible diagnosis and waitlist registration. METHODS: We investigated whether sociodemographic (age, sex, race, insurance, marital status, median household income) and clinical (FEV(1) % of predicted, body mass index, depression/anxiety, alcohol/substance misuse, absolute/relative contraindications) factors influenced referral and waitlist registration. We conducted a retrospective cohort study through chart review of hospitalized patients on the University of Chicago general medicine service from 2006–2014 meeting transplant-eligible criteria and ICD-9 billing codes for cystic fibrosis (CF) and pulmonary fibrosis (PF). We analyzed the times from transplant-eligibility to referral, work-up, and waitlist using Kaplan-Meier curves and log-rank tests. RESULTS: Overall, referral rates for transplant-eligible patients were 64%. Of those referred, approximately 36% reach the lung transplant waitlist. Referred CF patients were significantly more likely to reach the transplant waitlist than PF patients (CF 60% vs. PF 22%, p
Databáze: OpenAIRE